Last 20 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.01 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | -34.2% | -20.7% | -25.1% | -16.1% | -10.5% | -42.8% | -13.1% | -25.9% | -75.4% | -77.8% | -81.4% | -83.4% | |
| P/B Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | -32.7% | -18.9% | -47.2% | -40.9% | -25.2% | -52.2% | -22.6% | +0.5% | -42.5% | -7.3% | -42.1% | -53.1% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | 5.47 | 5.47 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Concord Medical Services Holdings Limited's operating margin was -72.1% in Q2 2025, down 0.0 pp QoQ and up 18.3 pp YoY. The trailing four-quarter average of -137.3% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 88.8% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -20.6% | -2.1% | -2.1% | -22.7% | -22.7% | -19.0% | -19.0% | -15.5% | -15.5% | -13.2% | -13.2% | -19.4% | -20.2% |
| — | +88.8% | +88.8% | -46.8% | -46.8% | -44.5% | -44.5% | +20.2% | +23.5% | -211.2% | -214.5% | -1.3% | -315.2% | |
| Operating Margin | -138.6% | -72.1% | -72.1% | -202.5% | -202.5% | -90.4% | -90.4% | -267.7% | -267.7% | 75.2% | 75.2% | -235.1% | -93.7% |
| — | +20.2% | +20.2% | +24.4% | +24.4% | -220.1% | -220.1% | -13.9% | -185.6% | +167.5% | +139.0% | +19.9% | +59.4% | |
| Net Margin | -80.3% | -13.5% | -13.5% | -82.3% | -82.3% | -78.7% | -78.7% | -81.7% | -81.7% | -32.0% | -32.0% | -114.4% | -61.9% |
| — | +82.8% | +82.8% | -0.8% | -0.8% | -146.2% | -146.2% | +28.6% | -32.1% | +75.3% | +79.4% | +32.3% | +50.3% |
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -18.3% | -0.8% | -0.8% | -4.2% | -3.8% | -4.5% | -4.7% | -5.9% | -5.4% | -2.2% | -2.2% | -7.9% | -3.5% |
| — | +82.4% | +82.7% | +28.9% | +28.7% | -105.8% | -111.8% | +24.9% | -53.1% | +40.6% | +23.8% | -96.5% | -8.5% | |
| ROA | -4.8% | -0.2% | -0.2% | -1.0% | -1.0% | -1.3% | -1.4% | -1.7% | -1.7% | -0.7% | -0.8% | -3.1% | -1.6% |
| — | +84.5% | +85.2% | +40.8% | +40.2% | -73.5% | -80.3% | +44.3% | -8.9% | +55.4% | +43.0% | -63.1% | -18.1% | |
| ROIC | -7.7% | -1.0% | -1.0% | -2.4% | -2.3% | -1.4% | -1.4% | -5.1% | -5.0% | 1.6% | 1.6% | -5.5% | -2.1% |
| — | +26.8% | +29.2% | +53.8% | +53.5% | -187.7% | -191.0% | +8.2% | -138.3% | +217.9% | +200.9% | -56.8% | +29.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 11.8% YoY to 0.42x, tightening the short-term liquidity position.
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.43 | 2.22 | 2.22 | 2.43 | 2.43 | 1.86 | 1.86 | 1.89 | 1.89 | 1.56 | 1.56 | 1.61 | 1.00 |
| — | +19.6% | +19.6% | +28.8% | +28.8% | +19.0% | +19.0% | +17.4% | +89.4% | +59.0% | +66.5% | +99.3% | +141.4% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | 23.62 | 23.62 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.46 | 0.42 | 0.42 | 0.46 | 0.46 | 0.47 | 0.47 | 0.32 | 0.32 | 0.64 | 0.64 | 0.68 | 0.73 |
| — | -11.8% | -11.8% | +46.4% | +46.4% | -25.6% | -25.6% | -53.3% | -56.5% | -51.8% | -45.7% | +50.5% | -48.5% | |
| Quick Ratio | 0.45 | 0.41 | 0.41 | 0.45 | 0.45 | 0.46 | 0.46 | 0.30 | 0.30 | 0.60 | 0.60 | 0.60 | 0.68 |
| — | -9.5% | -9.5% | +51.3% | +51.3% | -24.7% | -24.7% | -50.9% | -56.5% | -52.7% | -48.1% | +35.8% | -51.8% | |
| Interest Coverage | -2.75 | -1.74 | -1.74 | -2.87 | -2.87 | -3.15 | -3.15 | -8.88 | -8.88 | 2.72 | 2.72 | -16.91 | -6.16 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 20 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonConcord Medical Services Holdings Limited's current P/E is -0.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Concord Medical Services Holdings Limited's current operating margin is -138.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Concord Medical Services Holdings Limited's business trajectory between earnings reports.